Follow Up to: Does Tilray or MSOS benefit more from S3? -
UnderstandingCold219 Sep 15, 2021 "So for tilray they have to be able to sell into the US. That being said they do have the certs to sell medical through their EUGMP."
-
DaveHervey Sep 15, 2021 "Irwin Simon on TDR July 30th: With Certified GPM medical Cannabis facilities and NAFTA, TLRY will be able to export medical cannabis into the USA."
I think both these responses have merit as numerous Canadian facilities are currently exporting Canadian grown cannabis into the EU, GB, Aus, NZ, etc. I haven't heard of any US cannabis facilities legally exporting even though some Rec markets are flooded. I suspect the 'Golden Key' into the USA will be NAFTA / USMCA, and meeting Certified Cdn, US or EU GMP medical cannabis grades. Sch3 is classified as Medical Cannabis.
Canadian Export market has taken off since German legalization April 1. Re-Posted on X last night by StratCann https://stratcann.com/insight/canadas-wholesale-cannabis-market-shifting-from-buyers-to-sellers/
Starting in 2017 Canadian cannabis companies were exporting medical cannabis global. https://www.cbc.ca/news/business/medical-marijuana-canadian-export-1.4470407
In 2018 Tilray was already given approvals by the US DEA & FDA to ship medical cannabis for medical trials into the USA. "In September 2018, Tilray became the first Canadian cannabis company to legally export medical cannabis to the U.S. for a clinical trial. In December 2018, the company signed a deal with Novartis subsidiary Sandoz to sell, distribute and co-brand Tilray's non-smokeable/non-combustible medical cannabis products in legal markets worldwide." From Wikipedia (I believe this type of agreement and others similar were the reason Aphria, on the reverse take over of Tilray in May 2021, kept the Tilray name. Licensed Exporting of medical cannabis.)
NAFTA and the USMCA were renegotiated and came into law July 1, 2020.
I'm sure Irwin Simon has had legal people looking into exporting Medical Cannabis into the USA once Sch3 comes into law.
With Tilrays recent US beverages expansion & US Wellness foods expansion Tilray is likely to have in excess of $500M business in the US, this year. Further expansions into Infused Beverages, Medmen 3.0, expanding further into beverages will certainly take Tilray over $1 billion of business annually in the USA in the near future. On top of that Sch 3 2025 or 2026?
Copied from TLRY reddit